A Novel N-Tetrasaccharide In Patients With Congenital Disorders Of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, And Mannose Phosphate Lsomerase Deficiencies
Wenyue Zhang,Philip M. James,Bobby G. Ng,Xueli Li,Baoyun Xia,Jiang Rong,Ghazia Asif,Kimiyo Raymond,Melanie A. Jones,Madhuri Hegde,Tongzhong Ju,Richard D. Cummings,Katie Clarkson,Tim Wood,Cornelius F. Boerkoel,Hudson H. Freeze,Miao He
DOI: https://doi.org/10.1373/clinchem.2015.243279
IF: 12.114
2016-01-01
Clinical Chemistry
Abstract:BACKGROUND: Primary deficiencies in mannosylation of N-glycans are seen in a majority of patients with congenital disorders of glycosylation (CDG). We report the discovery of a series of novel N-glycans in sera, plasma, and cultured skin fibroblasts from patients with CDG having deficient mannosylation.METHOD: We used LC-MS/MS and MALDI-TOF-MS analysis to identify and quantify a novel N-linked tetrasaccharide linked to the protein core, an N-tetrasaccharide (Neu5Ac alpha 2,6Gal beta 1,4-GlcNAc beta 1,4GlcNAc) in plasma, serum glycoproteins, and a fibroblast lysate from patients with CDG caused by ALG1 [ALG1 (asparagine-linked glycosylation protein 1), chitobiosyldiphosphodolichol beta-mannosyltransferase], PMM2 (phosphomannomutase 2), and MPI (mannose phosphate isomerase).RESULTS: Glycoproteins in sera, plasma, or cell lysate from ALG1-CDG, PMM2-CDG, and MPI-CDG patients had substantially more N-tetrasaccharide than unaffected controls. We observed a >80% decline in relative concentrations of the N-tetrasaccharide in MPI-CDG plasma after mannose therapy in 1 patient and in ALG1-CDG fibroblasts in vitro supplemented with mannose.CONCLUSIONS: This novel N-tetrasaccharide could serve as a diagnostic marker of ALG1-, PMM2-, or MPI-CDG for screening of these 3 common CDG subtypes that comprise >70% of CDG type I patients. Its quantification by LC-MS/MS may be useful for monitoring therapeutic efficacy of mannose. The discovery of these small N-glycans also indicates the presence of an alternative pathway in N-glycosylation not recognized previously, but its biological significance remains to be studied. (C) 2015 American Association for Clinical Chemistry